您要查找的是不是:
- Compared CAF Combined with or without Paclitaxel in the Treatment of Advanced Breast Carcinoma. 加或不加泰素的CAF方案治疗转移性乳腺癌疗效观察
- The efficacy study of regimen CAF and CAP for the treatment of advanced breast carcinoma. CAF方案和CAP方案治疗晚期乳腺癌疗效
- The regimen CAF and CAP for the advanced breast carcinoma have got the same efficacy, but the toxicity of regimen CAF is lower. CAF方案和CAP方案均为治疗晚期乳腺癌的有效方案 ,但CAF方案的毒性小 ,病人易于耐受。
- Methods Forty two cases with advanced breast carcinoma were selected and divided to two groups randomly. Group A was treated with regimen CAF(CTX, ADM,FUDR). 方法 选择 42例晚期乳腺癌患者随机分为两组 ,A组接受CAF方案治疗 (CTX、ADM、FUDR)。
- Advanced breast carcinoma 晚期乳腺癌
- Survivin may be a new target for breast carcinoma therapy. survivin有望成为乳腺癌治疗的一个新靶点。
- Pictured here is the flow cytometry pattern of a breast carcinoma. 图示:乳腺癌流式细胞仪模式图。
- BSC accounted for only 0.36%(3/842)of all breast carcinoma in the same period. 乳腺分泌性癌仅占同期全部活检乳腺癌的0.;36%25;平均年龄48
- The chance for palliation and long-term survival is greater with metastatic breast carcinoma than with any other late malignant disease. 乳腺转移癌得到缓解和长期生存的机会大于其它恶性肿瘤的转移癌。
- Methods 64 patients with advanced breast cancer were divided into two groups: CTX, ADM and 5-Fu/CF c. i. 方法将64例晚期乳腺癌患者采用信封抽签法随机分组;CTX、ADM联合CF+5-Fu持续滴注方案为观察组;CAF方案为对照组;平均化疗2.;5个周期。
- Ang-2/Tie2 may play a critical role in promoting tumor angiogenesis and progression in human breast carcinoma. 结论:人乳腺癌中血管生成增加,Ang-2和Tie2在乳腺癌血管生成和进展中可能起重要作用。
- Objective To evaluate efficacy and toxicity of THP containing regimen in the treatment of advanced breast cancer. 目的应用吡柔比星为主联合化疗方案治疗晚期乳腺癌,评价其有效性及毒性。
- The positive expression rate of BMP-2 in 61 cases of breast carcinoma was 65.57%(40/61). BMP-2阳性表达率为65.;57%25(40/61)。
- Objective:To evaluate the effect of neoadjuvant therapy in the treatment of lo-cally advanced breast cancer. 探讨新辅助治疗在局部晚期乳腺癌治疗中的应用。
- The skin overlying the breast has prominent lymphatic spaces filled with small metastases from breast carcinoma. 乳腺皮肤有明显充满乳腺癌转移细胞的淋巴管腔。
- This review presents the present state and future prospect of neoadjuvant chemotherapy for advanced breast cancer. 现就新辅助化疗在乳腺癌治疗中的现状及展望作一综述。
- Methods Using immunohistochemistry of SP,20 cases of breast adenosis and 48 cases of breast carcinoma were examined. 方法应用免疫组织学SP法研究 2 0例乳腺腺病及 48例乳腺癌组织中E-CD、CD44H的表达。
- Objective To observe the efficacy and toxicity of advanced breast cancer treated with Navelbine(NVB)+Cisplatin(DDP). 目的观察长春瑞滨(NVB)、联合顺铂(DDP)治疗晚期乳腺癌的疗效和毒副反应。
- It can be a localized, firm area with scarring that can mimic a breast carcinoma. 它可因纤维化成为局限区以致于灰类似于乳腺癌外观。
- Objective To study the effect of interventio nal treatment on advanced breast cancer and rec urred breast cancer. 目的研究晚期乳腺癌及术后复发性乳腺癌的介入治疗方法及其临床意义。